№ lp_1_2_62515
File format: docx
Character count: 3113
File size: 16 KB
Macrolides are a class of antibiotics known for their mechanism of action, therapeutic uses, and potential side effects, commonly used for treating bacterial infections, especially for penicillin-allergic patients.
Year:
Not specified
Region / City:
Not specified
Theme:
Bacterial Protein Synthesis Inhibitors, Antibiotics
Document Type:
Research Article / Scientific Paper
Organ / Institution:
Not specified
Author:
Adimula Sharon Ebere
Target Audience:
Medical professionals, researchers
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2025
Region / City:
[insert local health board name]
Topic:
Clinical Guidelines for Antibiotics
Document Type:
Patient Group Directions (PGD)
Organ / Institution:
Welsh Medicines Advice Service
Author:
Jennifer Ellis, Dianne Burnett
Target Audience:
Community pharmacists, healthcare providers in Wales
Effective Period:
From 03 June 2025 to 02 June 2028
Approval Date:
21 February 2025
Amendments Date:
18 January 2025
Year:
2025
Region / city:
Not specified
Topic:
Antibiotic efficacy, nanotechnology
Document type:
Research article
Organization / institution:
Not specified
Author:
Diana Marcos Fernandez, Natalia Alfaro, Andrea Cutró, Diego Pazos-Castro, Inés Oliver Camacho, Luis Tebar Palmero, Ana Bouchet, Axel Hollmann
Target audience:
Researchers, healthcare professionals, microbiologists
Effective period:
Not specified
Approval date:
Not specified
Modification date:
Not specified
Year:
2021
Region / City:
Minnesota
Theme:
Environmental Impact, Antimicrobial Resistance, Water Resources
Document Type:
Research Proposal
Organization / Institution:
University of Minnesota - College of Veterinary Medicine
Author:
Randall Singer
Target Audience:
Researchers, Environmental Managers, Policy Makers
Period of Activity:
2021 - 2024
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2026
Region / State:
Tennessee, Iowa, Nebraska, USA
Topic:
Antibiotic use awareness
Document type:
Survey questionnaire
Organization:
Centers for Disease Control and Prevention, Division of Healthcare Quality Promotion
Prepared by:
CATMEDIA
Target audience:
Healthy adults visiting urgent care, community-dwelling older adults 65+, family caregivers of nursing home residents
Survey duration:
Approximately 20 minutes
Incentive:
$25 via Venmo, PayPal, or gift card
OMB Approval:
OMB No. 0920-1387, Expiration Date 03/31/2026
Consent:
Informed consent required for participation
Year:
2026
Region / City:
Not specified
Topic:
Health / Antibiotic Use
Document Type:
Educational Scenario
Target Audience:
Patients / General Public
Scenarios:
3
Key Themes:
Appropriate antibiotic use, patient decision-making, self-medication risks
Year:
Not specified
Region / City:
Not specified
Topic:
Antibiotic resistance
Document type:
Educational material
Organization / Institution:
Not specified
Author:
Not specified
Target audience:
Students, healthcare professionals
Period of validity:
Not specified
Date of approval:
Not specified
Date of changes:
Not specified
Year:
2018
Authors:
Trisha Calvo, Rachel Meltzer-Warren
Publisher:
Consumer Reports
Document type:
Article
Topic:
Food labeling, Antibiotics in meat and poultry
Region:
United States
Last updated:
November 30, 2018
Target audience:
General consumers
References:
USDA regulations, CDC data, Food and Drug Administration guidelines
Year:
2026
Region / City:
Not specified
Subject:
Pharmaceutical calculations, drug reconstitution
Document Type:
Educational worksheet
Institution / Organization:
Pharmacy education or training program
Author:
Not specified
Target Audience:
Pharmacy students or healthcare trainees
Period of validity:
2026
Date of preparation:
2026-02-27
Drug types covered:
Cefazolin, Ampicillin/Sulbactam, Amoxicillin, Ceftriaxone, Penicillin, Vancomycin, Zosyn, Streptomycin, Cefepime, Ceftazidime, Timentin, IVIG
Measurement units:
mL, g, mg/mL, MU
Application context:
Intravenous and oral drug reconstitution, dose calculation
Year:
1943
Region / city:
Not specified
Topic:
Antibiotics, pharmacology
Document type:
Scientific article
Organization / institution:
Not specified
Author:
Waksman
Target audience:
Medical professionals, researchers in pharmacology
Period of validity:
Not specified
Approval date:
Not specified
Date of changes:
Not specified
Year:
2020
Region / City:
Greater Accra Region, Ghana
Topic:
Antibiotic prescription and respiratory tract infections
Document type:
Research manuscript
Institution:
Department of Epidemiology and Disease Control, University of Ghana School of Public Health
Authors:
Idun-Acquah, J.J.; Harriet Affran Bonful (PhD)
Target audience:
Public health professionals, epidemiologists
Study design:
Retrospective cross-sectional study
Data collection site:
Tema Polyclinic
Key findings:
59.7% of outpatients received antibiotics, 63.3% of specific diagnoses were appropriately prescribed
Associated factors:
Laboratory investigations, breathlessness, headache, sputum production
Event:
Abstract accepted for West African Postgraduate College of Pharmacists 2020 AGM (cancelled due to COVID-19)
Email:
[email protected]
Phone:
+233244271821
Year:
1990–2016
Region / City:
International, multicenter
Topic:
Pediatric febrile urinary tract infections, antibiotic efficacy
Document Type:
Systematic review and meta-analysis
Institution / Organization:
St George’s University of London; University of Athens; Institut National de la Santé et de la Recherche Médicale, Université Paris Diderot; University Children’s Hospital Basel; University of Pennsylvania School of Medicine
Authors:
Konstantinos Vazouras, Romain Basmaci, Julia Bielicki, Laura Folgori, Theoklis Zaoutis, Mike Sharland, Yingfen Hsia
Study Population:
Children aged 0–18 years with febrile urinary tract infections without major underlying conditions
Number of Studies Reviewed:
30 clinical trials
Total Cases Analyzed:
3,913
Antibiotics Evaluated:
Cephalosporins, aminoglycosides, other antimicrobials
Key Outcomes:
Clinical cure rates, microbiological cure rates, treatment failure rates
Data Sources:
Medline, Embase, Cochrane Central
Inclusion Criteria:
Randomized clinical trials reporting on clinical and/or microbiological efficacy of antibiotics in pediatric febrile UTIs
Exclusion Criteria:
Lower urinary tract infections, patients with underlying conditions, long-term endpoints >1 month
Year:
2023
Region / City:
Oamaru, Waitaki District
Topic:
Antibiotics, Urinary Tract Infections, Aged Residential Care
Document Type:
Webinar
Organization:
Te Tāhū Hauora Health Quality & Safety Commission
Author:
Trish Bloxsom, Clinical Manager
Target Audience:
Healthcare professionals in aged care facilities
Duration of Action:
February 2023
Approval Date:
23 February 2023
Date of Changes:
N/A
Project Information:
HQSC invited to assist with a 10-week program
Clinical Governance Group:
Focused on UTI prevention
Aim:
Reduce incidents of treated UTIs from 10% to 5% by April 2021
Data:
UTIs decreased from 3.9 per month in 2020 to 0.8 in 2021
Process:
Fish bone tool used to identify barriers
Barriers:
Equipment shortages, medication availability, policy gaps
Note:
Context
Year:
2023
Region:
New Zealand
Topic:
Antimicrobial Stewardship, Urinary Tract Infections
Document type:
Webinar transcript
Organization:
Te Tāhū Hauora Health Quality & Safety Commission
Author:
Claire Underwood
Target audience:
Aged residential care professionals
Period:
23 February 2023
Video link:
https://www.youtube.com/watch?v=oOig8RNX2TM&list=PLqL5-6uWOmWfnW6mTl7BBSe3hSomPqXO5&index=4
Key subjects:
Ngā Paerewa standards, infection prevention, AMS programs, UTI management policies, staff and whānau education
Year:
2022
Region / City:
Maryland
Topic:
Pre-eclampsia, Magnesium toxicity
Document Type:
Case Study
Institution:
Carroll Community College
Author:
Christine Schlaerth, PhD, RN, CNM, WHNP-BC
Target Audience:
Nursing students, healthcare professionals
Period of validity:
N/A
Approval Date:
N/A
Date of modification:
N/A
Year:
2023
Region / City:
Minnesota
Topic:
Effluent Toxicity Testing
Document Type:
Report
Organization / Institution:
Minnesota Pollution Control Agency (MPCA)
Author:
Minnesota Pollution Control Agency (MPCA)
Target Audience:
Environmental regulators, facility operators, testing laboratories
Period of Effectiveness:
Ongoing (based on NPDES permit)
Approval Date:
Not specified
Modification Date:
Not specified
Year:
2023
Region / City:
Malaysia
Topic:
Life cycle toxicity assessment of wastewater treatment
Document Type:
Research article
Institution:
University of Southampton
Author:
Siti Safirah Rashid, Yong-Qiang Liu
Target Audience:
Researchers, environmental engineers, policy makers
Period of validity:
Not specified
Date of approval:
Not specified
Date of changes:
Not specified
Year:
2017
Region / city:
Victoria, ACT
Topic:
Drug safety, harm reduction
Document type:
Advisory notice
Organization:
Harm Reduction Victoria
Author:
Not specified
Target audience:
Public, drug users, healthcare professionals
Effective date:
Not specified
Date of approval:
Not specified
Date of amendments:
Not specified
Context:
Warning about the presence of dangerous synthetic drugs 25C-NBOMe and 4-FA sold as ‘2C-B’, with information on their adverse effects and harm reduction.
Year:
2023
Region / City:
Ohio, USA
Topic:
Nanotechnology, RNA Nanoparticles, Cancer Targeting
Document Type:
Research Article
Organization / Institution:
The Ohio State University, Wexner Medical Center
Author:
Hongzhi Wang, Chiran Ghimire, Hui Li, Mario Vieweger, Congcong Xu, Peixuan Guo
Target Audience:
Researchers, Scientists, Medical Professionals
Period of Validity:
N/A
Approval Date:
N/A
Date of Changes:
N/A
Note:
Context
Year:
2018
Region / city:
Alfred, NY
Subject:
Biology, Biochemistry
Document type:
Research article
Organization / institution:
Alfred University, Department of Biology
Author:
Geoffrey Lippa
Target audience:
Students in biological sciences
Period of validity:
N/A
Date of approval:
N/A
Date of changes:
N/A
Year:
2002
Product name:
Abine (Abamectina 1.8% p/v)
Active substance:
Abamectin
Study type:
Acute oral toxicity study; Acute dermal toxicity study
Test guidelines:
OECD No. 423; OECD No. 402
GLP compliance:
Yes
Laboratory:
Jai Research Foundation
Location:
Valvada 396 108; Gujarat; India
Author:
Aldrin Joseph, S.
Document numbers:
JRF 3719; JFR 3720
Test species:
Rat (Wistar)
Sex:
Male and female
Route of administration:
Oral (gavage); Dermal (semi-occlusive, 24 h)
Dose levels:
200, 500, 2000 mg/kg bw (oral); 2000 mg/kg bw (dermal)
Oral LD50:
500–2000 mg/kg bw
Dermal LD50:
> 2000 mg/kg bw
Observation period:
14 days
Regulatory references:
Directive 2001/59/EC; Regulation (EC) 1272/2008; Council Directive 67/548/EC
Hazard classification:
R22 (Harmful if swallowed); H302 (Harmful if swallowed); H318 (Causes serious eye damage)